Phage bet-hedging and EBV antibodies

Podcast: This Week in Virology · Vincent Racaniello

Opublikowano: 2026-08-30

TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising step toward Epstein-Barr therapeutics. Hosts: Vincent Racaniello, Rich Condit, Brianne Barker, and Jolene Ramsey Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Dolly Parton, and advocate for science (Nature) Phage bet-hedging (Nat Micro) EBV monoclonal antibodies (Cell Rep Med) Letters read on TWiV 1353 Timestamps by Jolene Ramsey. Thanks! Picks of the Week <...